Publications by authors named "Marion Weigel"

Claim this Profile
E
Evaluation of Laparoscopy Virtual Reality Training on the Improvement of Trainees' Surgical Skills.
Mohamed Elessawy, Mohamed Mabrouk, Thorsten Heilmann, Marion Weigel, Mohamed Zidan

Medicina (Kaunas)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vulvar cancer: epidemiology, clinical presentation, and management options.
Ibrahim Alkatout, Melanie Schubert, Nele Garbrecht, Marion Tina Weigel, Walter Jonat

Int J Womens Health· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancer.
Nicolai Maass, Christian Schem, Dirk O Bauerschlag, Katharina Tiemann, Fritz W Schaefer, Marion T Weigel

Oncology· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib in combination with carboplatin and paclitaxel is a candidate for ovarian cancer treatment.
Marion T Weigel, Katrin Rath, Ibrahim Alkatout, Antonia S Wenners, Christian Schem

Oncology· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hysterectomy trends over a 9-year period in an endoscopic teaching center.
Thoralf Schollmeyer, Mohamed Elessawy, Babis Chastamouratidhs, Ibrahim Alkatout, Ivo Meinhold-Heerlein, Marion T Weigel

Int J Gynaecol Obstet· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of syndecan-1 expression in ductal carcinoma in situ of the breast.
Katharina Tiemann, Marion Tina Weigel, Ibrahim Alkatout, Antonia Sophie Wenners, Heidi Mundhenke

Anticancer Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo.
Lesley-Ann Martin, Sunil Pancholi, Ian Farmer, Stephanie Guest, Ricardo Ribas, Marion T Weigel

Breast Cancer Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer.
Marion T Weigel, Zara Ghazoui, Anita Dunbier, Sunil Pancholi, Mitch Dowsett

Breast Cancer Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carcinoma.
Marion T Weigel, Julia Krämer, Christian Schem, Antonia Wenners, Ibrahim Alkatout

Eur J Obstet Gynecol Reprod Biol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-free survival in ovarian cancer is reflected in epigenetic DNA methylation profiles.
Dirk O Bauerschlag, Ole Ammerpohl, Karen Bräutigam, Christian Schem, Qiong Lin, Marion T Weigel

Oncology· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and emerging biomarkers in breast cancer: prognosis and prediction.
Marion T Weigel, Mitch Dowsett

Endocr Relat Cancer· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer.
Lesley-Ann Martin, Giles L S Davies, Marion T Weigel, Nadine Betambeau, Margaret J Hills

Breast Cancer Res Treat· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunitinib (SU11248) inhibits growth of human ovarian cancer in xenografted mice.
Dirk O Bauerschlag, Christian Schem, Sanjay Tiwari, Jan H Egberts, Marion T Weigel

Anticancer Res· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells.
Marion T Weigel, Linda Dahmke, Christian Schem, Dirk O Bauerschlag, Katrin Weber

BMC Cancer· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leiomyomatosis peritonealis disseminata in a pregnant woman.
Birte Summa, Christian Schem, Marion Weigel, Alexander Strauss, Walter Jonat

Arch Gynecol Obstet· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer.
Dirk O Bauerschlag, Christian Schem, Marion T Weigel, Constantin Von Kaisenberg, Alexander Strauss

J Cancer Res Clin Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of enzastaurin and pemetrexed inhibits cell growth and induces apoptosis of chemoresistant ovarian cancer cells regulating extracellular signal-regulated kinase 1/2 phosphorylation.
Karen Bräutigam, Dirk Olaf Bauerschlag, Marion Tina Weigel, Julia Biernath-Wüpping, Thomas Bauknecht

Transl Oncol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling.
Marion T Weigel, Ivo Meinhold-Heerlein, Dirk O Bauerschlag, Christian Schem, Maret Bauer

Cancer Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects.
Christoph Mundhenke, Marion Tina Weigel, Klarissa Hanja Sturner, Frank Roesel, Ivo Meinhold-Heerlein

J Cancer Res Clin Oncol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis